Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
A Prospective, Controlled, Double Blind, Multi-Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Sponsor: AOBiome LLC
A PHASE1/PHASE2 clinical study on Allergic Rhinitis and Allergic Rhinitis Due to Grass Pollen, this trial is completed. The trial is conducted by AOBiome LLC and has accumulated 12 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Apr 2022 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Apr 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 7 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jul 2019 — Aug 2020 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Apr 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AOBiome LLC
- Integrium
- Orange County Research Center
For direct contact, visit the study record on ClinicalTrials.gov .